Essential role of nitric oxide and interferon-γ for tumor immunotherapy with interleukin-10

Journal of Immunotherapy

Volumn 23, Issue 2, 2000, Pages 208-214

  Sun, Hui ^a,b   Gutierrez, Peter ^a   Jackson, Marian J ^b   Kundu, Namita ^a,b   Fulton, Amy M ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Aminoguanidine; Interferon ; Interleukin 10; L NIL; Nitric oxide; Nitric oxide hemoglobin; Tumor inhibition

Indexed keywords

AMINOGUANIDINE; GAMMA INTERFERON; HEME; HEMOGLOBIN; INTERLEUKIN 10; MESSENGER RNA; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RECOMBINANT INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; FEMALE; GENE TRANSFER; GENETIC TRANSDUCTION; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; IMMUNOTHERAPY, ACTIVE; INTERFERON TYPE II; INTERLEUKIN-10; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034019537     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200003000-00005     Document Type: Article

References (35)

1. Richter G, Kruger-Krasagakes S, Hein G, et al. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res 1993;53:4134-7.
2. Giovarelli M, Musiani P, Modesti A, et al. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J Immunol 1995;155:3112-23.
3. Berman RM, Suzuki T, Tahara H, et al. Systemic administration of cellular IL-10 induces an effective, specific and long-lived immune response against established tumors in mice. J Immunol 1996;157: 231-8.
4. Huang S, Zie K, Bucana CD, Ullrich SE, Bar-Eli M. Interleukin-10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin Cancer Res 1996;2: 1969-79.
5. Zhang, LM, Ojcius DM, Garaud F, et al. Interleukin 10 inhibits tumor metastasis through an NK cell dependent mechanism. J Exp Med 1996;184:579-84.
6. Kundu N, Beaty TL, Jackson MJ, Fulton AM. Antimetastatic and antitumor activities of interleukin-10 in a murine model of breast cancer. J Natl Cancer Inst 1996;88:536-41.
7. Kundu N, Fulton AM. Interleukin 10 inhibits tumor metastasis, downregulates MHC class I and enhances NK lysis. Cell Immunol 1997;180:55-61.
8. Kundu N, Dorsey R, Jackson MJ, et al. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide. Int J Cancer 1998;76:713-19.
9. Xie Q-W, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256:225-8.
10. Lowenstein CJ, Alley EW, Raval P, et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by Interferon-γ and lipopolysaccharide. Proc Natl Acad Sci 1993;90: 9730-34.
11. Corbett JA, McDaniel M. Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Methods Enzymol 1996;268: 398-408.
12. Sun H, Jackson MJ, Kundu N, Fulton AM. Interleukin-10 gene transfer activates interferon-γ and the interferon-γ-inducible genes Gbp-1/Mag-1 and Mig-1 in mammary tumors. Int J Cancer 1999; 80:624-9.
13. Bastien NR, Yim C-Y, Hibbs JB, Samlowski WE. Induction of iron-derived EPR signals in murine cancers by nitric oxide. J Biol Chem 1994;269:5127-31.
14. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
15. Cunha FQ, Moncada S, Liew FY. Interleukin 10 inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 1992;182:1155-9.
16. Appelberg R. Opposing effects of interleukin-10 on mouse macrophage functions. Scand J Immunol 1995;41:539-44.
17. Loftis LL, Meals EA, English BK. Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J Infect Dis 1997;175:1008-1011.
18. Corradin SB, Fasel N, Buchmuller-Rouiller Y, et al. Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10. Eur J Immunol 1993; 23:2045-8.
19. Sunyer T, Rothe L, Jiang S, Osdoby P, Collin-Osdoby P. Proinflammatory agents, IL-8 and IL-10 upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells. J Cell Biochem 1996;60:469-83.
20. Stefano GB, Christensen VB, Tonnesen E, et al. Interleukin-10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence. J Cardiovasc Pharm 1997;30:90-5.
21. Hibbs JB, Vavrin Z, Taintor RR. L-arginine is required for the expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987; 138:550-65.
22. Stuehr DJ, Nathan C. Nitric oxide, a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989;169:1543-55.
23. Sarih M, Souvannavong V, Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 1993;191:503-8.
24. Maragos CM, Wang JM, Hrabie JA, Oppenheim JJ, Keefer LK. Nitric oxide-nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res 1993;53:564-8.
25. Li L, Kilbourn RG, Adams J, Fidler IJ. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res 1991;51:245-54.
26. Xie K, Huang S, Dong Z, et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995; 181:1333-43.
27. Sandau K, Pfeilschifter J, Brune B. The balance between nitric oxide and superoxide determines apoptotic and necrotic death of rat mesangial cells. J Immunol 1997;158:4938-46.
28. Yamashita T, Uchida T, Araki A, Sendo F. Nitric oxide is an effector molecule in inhibition of tumor cell growth by rIFN-γ-activated rat neutrophils. Int J Cancer 1997;71:223-30.
29. Cook JA, Krishna MC, Pacelli R, et al. Nitric oxide enhancement of melphalen-induced cytotoxicity. Br J Cancer 1997;76:325-34.
30. Radomski MW, Jenkins DC, Holmes LS, Moncada S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 1991; 51:6073-8.
31. Tamir S, DeRojas-Walker T, Wishnok JS, Tannebaum SR. DNA damage and genotoxicity by nitric oxide. Meth Enzymol 1996;269: 230-43.
32. Wink DA, Kasprzak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001-3.
33. Moochhala S, Chhatwal VJS, Chan STT, et al. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogen 1996;17:1171-4.
34. Jenkins DC, Charles IG, Thomsen LL, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci 1995;92:4392-6.
35. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. Br J Cancer 1996;73:189-96.